Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Device
Medical Devices

Nuwellis AquaFlexFlow UF 500 Plus Recalled for Fluid Imbalance Risk

Agency Publication Date: January 16, 2025
Share:
Sign in to monitor this recall

Summary

Nuwellis Inc is recalling 845 units of the AquaFlexFlow UF 500 Plus extracorporeal blood circuit. This component, used with Aquadex SmartFlow and FlexFlow systems, may trigger "Ultrafiltrate Weight Mismatch" or "Excessive Weight Mismatch" alarms during use. While no injuries have been reported, this defect can lead to incorrect fluid removal from patients. Consumers should contact the manufacturer or their medical distributor to arrange for a return or replacement of affected units.

Risk

The device failure can result in excessive fluid removal from a patient, leading to acute volume depletion. This condition is especially dangerous for pediatric patients who are more vulnerable to rapid changes in blood volume.

What You Should Do

  1. This recall involves the Nuwellis AquaFlexFlow UF 500 Plus (REF 114156, Catalog Number A06163) extracorporeal blood circuit used with Aquadex SmartFlow or Aquadex FlexFlow systems.
  2. To determine if your product is affected, check the lot number printed on the device packaging. See the Affected Products section below for the full list of affected codes.
  3. Stop using the recalled device immediately. Contact Nuwellis Inc or your medical distributor to arrange for the return, replacement, or correction of your inventory.
  4. Call the FDA at 1-888-463-6332 (1-888-INFO-FDA) for additional questions regarding this recall.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer correction or return

How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: nuwellis AquaFlexFlow UF 500 Plus extracorporeal blood circuit
Model / REF:
A06163
114156
Lot Numbers:
22697
22698
22699
22700
22701
22702
22703
22704
22705
22706
22707
22708
22721
22722
22723
22724
22733
22734
22735
22736
22737
22738
22739
22740

Used with Aquadex SmartFlow or Aquadex FlexFlow System; Recall #: Z-0831-2025

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 95991
Status: Resolved
Manufacturer: Nuwellis Inc
Sold By: Hospital suppliers; Medical device distributors
Manufactured In: United States
Units Affected: 845 units
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.